The health system and biotech company are collaborating to create a Covid-19 patient registry biobank, which will combine de-identified patient data and AI technology to identify characteristics and trends that have an impact on disease outcomes.
Berg, a Boston biotech, has a strong artificial intelligence platform for drug discovery. It has several drugs in its pipeline, and is leading an effort to discover the very first biomarker for pancreatic cancer.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
As far as medical science has advanced, we’ve still not come close to paralleling the amazing natural processes that go on, every day, in the human body. Berg, a Boston-area startup, builds off that concept of studying healthy tissues to understand the body’s molecular and cellular natural defenses – and what leads to a disease’s […]